Zealand Pharma A/S
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
Other Names/Subsidiaries
- Encycle Therapeutics, Inc.
- Valeritas Holdings, Inc.
Latest on Zealand Pharma A/S
MaaT013 (allogeneic fecal microbiota, pooled), from MaaT Pharma, and Zealand Pharma’s glepaglutide are among the latest new products that the European Medicines Agency has begun reviewing for potentia
While GLP-1 receptor agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) continue to dominate global headlines and investor interest in the obesity space, one UK biotech is quietly building
Already riding high with positive early data for its long-acting GLP-1 analog candidate MET-097i, Metsera grabbed attention again on June 9 with Phase I data for its amylin analog MET-233i, which prod
Biopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso